×

BRIEF-Boston Therapeutics to file new drug application for diabetes drug

Oct 4 (Reuters) - Boston Therapeutics Inc :

* Wins FDA approval to file an abbreviated new drug application for Pazamet(TM)

to treat diabetes

* Says company plans to market the new formulation under the name pazamet

((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))

((For more news, please click here ))